Leiv Lea insider trades
Open-market stock purchases and sales by Leiv Lea, Chief Financial Officer at Corvus Pharmaceuticals, Inc, from SEC Form 4 filings since Mar 22, 2016.
Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +203%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 4, 2025 | CRVS Corvus Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- CRVS Corvus Pharmaceuticals, Inc: 7 buys, last Dec 4, 2025